Both companies say their drugs will work against the Omicron variant, though this is based on preliminary, lab-based research.
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
Ivermectin has been a lifesaving drug for people with parasitic infections like river blindness and strongyloidiasis. But taking it for COVID-19 may result in the opposite effect.
Merck announced preliminary data suggesting the drug reduced the risk of hospitalisation and death by 50%.
The COVID pandemic is giving drug companies an opportunity to reset their image. So how did they get so big and their credibility sink so low?
Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won’t happen unless people believe it’s safe.
Trump’s reaction to the violence in Charlottesville, Virginia, prompted business leaders to sever ties with two White House councils.
New drug combination cures over 95% of cases but the cost would swallow the entire health budget. Pity the politicians that have to figure this one out.